HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tokumura, A. Articles by Fukuzawa, K. Search for Related Content PubMed PubMed Citation Articles by Tokumura, A. Articles by Fukuzawa, K. Agricola Articles by Tokumura, A. Articles by Fukuzawa, K.

Increased Production of Bioactive Lysophosphatidic Acid by Serum Lysophospholipase D in Human Pregnancy¹

^a Laboratory of Health Chemistry, Faculty of Pharmaceutical Sciences, The University of Tokushima, Shomachi, Tokushima 770-8505, Japan ^b Department of Obstetrics and Gynecology, School of Medicine, The University of Tokushima, Kuramoto-cho, Tokushima 770-8503, Japan

Lysophosphatidic acid (LPA) is a prototype of the lysophospholipid mediator family and has multiple effects in the female reproductive system. Although several metabolic routes have been reported for intracellular formation of LPA, a unique route involving lysophospholipase D, an extracellular enzyme that produces LPA in blood and body fluids, is particularly intriguing for its agonistic role. In this study, using an assay with radioactive palmitoyl-lysophosphatidylcholine, we found that lysophospholipase D activity producing palmitoyl-LPA in human serum gradually increased during pregnancy. Elevated activity of lysophospholipase D was not caused by changes in levels of their precursors, lysophosphatidylcholines, in nonpregnant women or in pregnant women at different gestational periods. With increasing length of gestation, the elevated activity in pregnant women was found to produce increasing proportions of LPA with a palmitoyl group versus other LPAs. These results suggest that LPA formed by increased activity of lysophospholipase D in blood might participate in maintenance of pregnancy.

¹ Supported in part by a Grant-in-Aid for scientific research (C) from the Ministry of Education, Culture, Sports and Technology of the Japanese government.

² Correspondence: Akira Tokumura, Faculty of Pharmaceutical Sciences, The University of Tokushima, 1-78-1 Shomachi, Tokushima 770-8505, Japan. FAX: 81 88 633 9572; tokumura{at}ph.tokushima-u.ac.jp

This article has been cited by other articles:

				H. Zhang, X. Xu, J. Gajewiak, R. Tsukahara, Y. Fujiwara, J. Liu, J. I. Fells, D. Perygin, A. L. Parrill, G. Tigyi, et al. Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo Cancer Res., July 1, 2009; 69(13): 5441 - 5449. [Abstract] [Full Text] [PDF]

				A. Tokumura, T. Kume, S. Taira, K. Yasuda, and H. Kanzaki Altered activity of lysophospholipase D, which produces bioactive lysophosphatidic acid and choline, in serum from women with pathological pregnancy Mol. Hum. Reprod., May 1, 2009; 15(5): 301 - 310. [Abstract] [Full Text] [PDF]

				E. Liszewska, P. Reinaud, E. Billon-Denis, O. Dubois, P. Robin, and G. Charpigny Lysophosphatidic Acid Signaling during Embryo Development in Sheep: Involvement in Prostaglandin Synthesis Endocrinology, January 1, 2009; 150(1): 422 - 434. [Abstract] [Full Text] [PDF]

				I. Woclawek-Potocka, J. Komiyama, J. S. Saulnier-Blache, E. Brzezicka, M. M. Bah, K. Okuda, and D. J Skarzynski Lysophosphatic acid modulates prostaglandin secretion in the bovine uterus Reproduction, January 1, 2009; 137(1): 95 - 105. [Abstract] [Full Text] [PDF]

				S.-U. Chen, H. Lee, D.-Y. Chang, C.-H. Chou, C.-Y. Chang, K.-H. Chao, C.-W. Lin, and Y.-S. Yang Lysophosphatidic Acid Mediates Interleukin-8 Expression in Human Endometrial Stromal Cells through Its Receptor and Nuclear Factor-{kappa}B-Dependent Pathway: A Possible Role in Angiogenesis of Endometrium and Placenta Endocrinology, November 1, 2008; 149(11): 5888 - 5896. [Abstract] [Full Text] [PDF]

				X. Ye Lysophospholipid signaling in the function and pathology of the reproductive system Hum. Reprod. Update, September 1, 2008; 14(5): 519 - 536. [Abstract] [Full Text] [PDF]

				E. Billon-Denis, Z. Tanfin, and P. Robin Role of lysophosphatidic acid in the regulation of uterine leiomyoma cell proliferation by phospholipase D and autotaxin J. Lipid Res., February 1, 2008; 49(2): 295 - 307. [Abstract] [Full Text] [PDF]

				J. Ren, Y.-j. Xiao, L. S. Singh, X. Zhao, Z. Zhao, L. Feng, T. M. Rose, G. D. Prestwich, and Y. Xu Lysophosphatidic Acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells. Cancer Res., March 15, 2006; 66(6): 3006 - 3014. [Abstract] [Full Text] [PDF]

				L. T. Budnik and B. Brunswig-Spickenheier Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor J. Lipid Res., May 1, 2005; 46(5): 930 - 941. [Abstract] [Full Text] [PDF]

				T. M. McIntyre, A. V. Pontsler, A. R. Silva, A. St. Hilaire, Y. Xu, J. C. Hinshaw, G. A. Zimmerman, K. Hama, J. Aoki, H. Arai, et al. From the Cover: Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist PNAS, January 7, 2003; 100(1): 131 - 136. [Abstract] [Full Text] [PDF]